Related Experiment Video

Updated: Jun 19, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies

He Yuling1, Xiao Ruijing, Li Li

  • 1Department of Immunology, and Laboratory of Allergy and Clinical Immunology, Institute of Allergy and Immune-related Diseases, Center for Medical Research, Wuhan University School of Medicine, Wuhan, People's Republic of China.

Cancer Research
|October 8, 2009
PubMed

Insights

Natural killer T (NKT) cells play a role in cancer immunity. This study shows EBV-induced CD8(+) NKT cells can suppress tumors and enhance T-cell responses against EBV-associated cancers.

Area of Science:

  • Immunology
  • Oncology
  • Virology

Background:

  • The role of Natural Killer T (NKT) cells in human tumor immunosurveillance is not fully understood.
  • NKT cells are crucial immune cells involved in recognizing lipid antigens and bridging innate and adaptive immunity.
  • Epstein-Barr virus (EBV) is associated with several human malignancies, including Hodgkin's lymphoma and nasopharyngeal carcinoma.

Purpose of the Study:

  • To elucidate the mechanism of NKT cells in EBV-associated tumor immunosurveillance.
  • To investigate the functional differences between CD4(+) and CD8(+) NKT cells in the context of EBV infection and cancer.
  • To evaluate the therapeutic potential of EBV-induced NKT cells in treating EBV-associated malignancies.

Main Methods:

  • Comparative analysis of NKT cell frequencies and function in EBV-associated cancer patients versus healthy carriers.
  • Utilizing human-thymus-severe combined immunodeficient (hu-thym-SCID) chimeras for in vivo studies of EBV challenge and NKT cell generation.
  • Employing humanized xenogeneic tumor models to assess the impact of adoptive NKT cell transfer on tumorigenesis.

Main Results:

  • Patients with EBV-associated cancers exhibit significantly lower frequencies of functional CD8(+) NKT cells compared to healthy EBV carriers.
  • EBV challenge in hu-thym-SCID chimeras promotes the generation of cytotoxic, IFN-gamma-biased CD8(+) NKT cells that enhance T-cell anti-tumor immunity.
  • Adoptive transfer of EBV-induced CD8(+) NKT cells suppressed tumor growth in humanized xenogeneic models, with CD4(+) NKT cells showing synergistic effects.

Conclusions:

  • EBV-induced CD8(+) NKT cells are critical for enhancing T-cell immunity against EBV-associated malignancies.
  • Immune reconstitution with EBV-induced CD8(+) NKT cells represents a promising therapeutic strategy for managing EBV-associated cancers.
  • Understanding NKT cell subsets and their functions is key to developing effective immunotherapies for viral-associated cancers.

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...